Compare Johnson & Johnson (JNJ) vs Carparts.Com Inc (PRTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Carparts.Com Inc — how do they compare? Johnson & Johnson trades at $261.35 (market cap $618.09B), while Carparts.Com Inc trades at $8.51 (market cap $66.42M). The key difference: Johnson & Johnson is far larger — about 9305.8× Carparts.Com Inc's market cap, and Johnson & Johnson pays a 2.09% dividend while Carparts.Com Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Carparts.Com Inc for 45 Days on average.
| JNJ | PRTS | |
|---|---|---|
Market Cap | $618.09B | $66.42M |
Volume | 6,050,983 | 40,287 |
Sector | Health | Consumer Cyclical |
52-Week High | $278.43 | $10.00 |
52-Week Low | $186.00 | $3.88 |
Typical Hold Time | 129 Days | 45 Days |
Enterprise Value | $646.37B | $79.39M |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $259.62, up 0.45% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 21.48% net margin and 25.74% ROE, though valuation ratios appear elevated with P/E at 29.75. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with 52.5% buy ratings.
JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and increasing debt-to-asset ratio (24.06% in 2025). Analyst consensus target of $286.53 suggests 10% upside potential, though technical resistance at $260 may limit near-term gains.
PRTS trades at $8.51, down 2.13% today, with a bullish technical signal from moving averages. The company reported three consecutive quarterly earnings beats but remains unprofitable with negative margins. Revenue has declined from $676M in 2023 to $548M in 2025, though net losses improved in recent quarters. Analyst sentiment is positive with 60% buy ratings.
The outlook balances technical strength against fundamental challenges. While the stock shows bullish momentum and analyst support, persistent losses and declining revenue pose significant risks. Investment opportunity exists if the company can stabilize revenue and achieve profitability, but current financial performance warrants caution despite positive earnings surprises.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Carparts.Com Inc
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Read more on PRTS →
